论文部分内容阅读
目的:探讨运用精细肝脏外科理念治疗肝血管瘤的价值。方法:回顾性分析行肝切除的52例肝血管瘤患者的临床资料,其中采用精细肝切除术23例,传统肝切除术29例。结果:52例患者均手术成功,术后顺利康复,术中及围手术期无严重并发症,无死亡发生。精细肝切除组与传统肝切除组比较,前者手术时间延长[(128.0±25.7)min vs.(100.9±20.4)min](P<0.05),术中出血、输血例数比例差异均无统计学意义(均P>0.05),术后住院时间明显缩短[(7.0±1.5)d vs.(8.6±1.5)d](P<0.05),术后丙氨酸氨基转移酶(ALT)峰值[(277.5±189.3)U/L vs.(960.0±635.0)U/L],门冬氨酸氨基转移酶(AST)峰值[(254.2±191.4)U/L vs.(838.5±677.1)U/L]以及术后并发症发生率均明显降低(8.7%vs.31.0%)(均P<0.05)。结论:运用精细肝脏外科理念治疗肝血管瘤安全有效,较传统肝切除术具有明显优势。
Objective: To explore the value of using fine liver surgery to treat hepatic hemangiomas. Methods: The clinical data of 52 patients with hepatic hemangiomas underwent hepatectomy were analyzed retrospectively. Twenty - three patients underwent hepatectomy and 29 patients underwent conventional hepatectomy. Results: All the 52 patients were successful in operation and successfully recovered after operation. No serious complications occurred during the operation and perioperative period, and no death occurred. Compared with the conventional hepatectomy group, the former had a longer operative time (128.0 ± 25.7 min vs. 100.9 ± 20.4 min, P <0.05), and there was no significant difference in the number of bleeding and transfusion (P <0.05). The length of postoperative hospital stay was significantly shorter than that of the control group (P <0.05). The postoperative ALT peak time [(7.0 ± 1.5) d vs. (8.6 ± 1.5) 277.5 ± 189.3) U / L vs. (960.0 ± 635.0) U / L], aspartate aminotransferase (AST) peak [(254.2 ± 191.4) U / L vs. (838.5 ± 677.1) U / L] As well as the incidence of postoperative complications were significantly lower (8.7% vs.31.0%) (all P <0.05). Conclusion: It is safe and effective to treat hepatic hemangiomas with the concept of fine liver surgery, which has obvious advantages over traditional hepatectomy.